about
Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranesAdiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration.Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron diseaseStem cell therapy for neurodegenerative diseases: the issue of transdifferentiation.Stem cells: From embryology to cellular therapy? An appraisal of the present state of art.Stem cell transplantation in multiple sclerosis: safety and ethics.Dose dependent side effect of superparamagnetic iron oxide nanoparticle labeling on cell motility in two fetal stem cell populationsStem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement?Amyotrophic lateral sclerosis: applications of stem cells - an update.Neurorescue effects and stem properties of chorionic villi and amniotic progenitor cells.Stem cell therapy: how to do it right.Phenotypic Modulation and Neuroprotective Effects of Olfactory Ensheathing Cells: a Promising Tool for Cell Therapy.Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.NMR Metabolomics for Stem Cell type discrimination.Vascular and parenchymal lesions along with enhanced neurogenesis characterize the brain of asymptomatic stroke-prone spontaneous hypertensive rats.Neuro-glial differentiation of human bone marrow stem cells in vitro.Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential.Basic fibroblast growth factor supports the proliferation of epidermal growth factor-generated neuronal precursor cells of the adult mouse CNSThe role of interleukin-6 (IL-6) in the proliferation and differentiation of human neural stem cellsHuman neural stem cells express extra-neural markersPrefaceMetalloproteinase alterations in the bone marrow of ALS patientsNeuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease
P50
Q28249379-EA9A5CF1-6416-4205-B7DA-1786DCA05425Q33582007-41561F5E-25C1-42CF-AE28-10A7FDFA9B7EQ34041845-E4BA44D6-6C1D-4E9B-99CB-60A68B3D63A4Q34182540-94158517-3835-465C-A70E-4BFF29E68E2FQ35739789-67BE0972-A533-4B45-9547-63D9EAF4261BQ36254634-0DA3712D-8F2F-4E93-AB02-B53D300B70EBQ36873863-36FA9980-B10D-43B7-876F-0189B1ED8CF9Q37288491-DA926B12-B3E4-4BF8-9118-531C0442633DQ37734501-7E42EA63-8039-40B0-8ABA-437DC6B0F7B7Q38160459-4EF51C5A-89F0-4303-BF75-8CC7AE0B957CQ39216063-021B7BCE-A9D4-4377-A634-CEB921AB6B7DQ41858276-945AE101-0362-481E-919F-540CBF50B79DQ42484904-697C370B-659A-4356-8FE0-326F58F5E525Q43234179-40645A62-250B-4513-A4CB-9790A1A583E2Q45845978-B1234DF1-1A41-421E-A61A-B57DC9C62335Q46449687-880DC729-D00D-4D71-B1B9-F34D6B4D2BD8Q50970550-8F789A8C-65E1-4413-BCC4-9C480BE863EDQ55041824-30036D6B-7648-4B46-9A53-B0AEC0804149Q60724122-1B46DB3F-E909-4167-BE41-1F4829F0E88CQ61853280-C78AF0DA-B1C8-45DF-A6AE-3FA6C3EB5E21Q77492188-6D8876B5-9A52-4D53-87F6-124846409D59Q82576411-15DD6D38-BAFB-4386-AEE7-46A743EB98FEQ82595342-5723724D-D6C7-4EC1-9483-514B711EC469Q82909857-2D6CB02B-D085-4B6F-B546-1B498F23E3FA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
L Cova
@ast
L Cova
@en
L Cova
@es
L Cova
@nl
type
label
L Cova
@ast
L Cova
@en
L Cova
@es
L Cova
@nl
prefLabel
L Cova
@ast
L Cova
@en
L Cova
@es
L Cova
@nl
P106
P1153
7006616710
P31
P496
0000-0002-1504-1556